248 related articles for article (PubMed ID: 16051228)
1. Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB.
Cho M; Gwak J; Park S; Won J; Kim DE; Yea SS; Cha IJ; Kim TK; Shin JG; Oh S
FEBS Lett; 2005 Aug; 579(20):4213-8. PubMed ID: 16051228
[TBL] [Abstract][Full Text] [Related]
2. Polysiphonia japonica extract suppresses the Wnt/beta-catenin pathway in colon cancer cells by activation of NF-kappaB.
Gwak J; Park S; Cho M; Song T; Cha SH; Kim DE; Jeon YJ; Shin JG; Oh S
Int J Mol Med; 2006 Jun; 17(6):1005-10. PubMed ID: 16685408
[TBL] [Abstract][Full Text] [Related]
3. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
4. RelA suppresses the Wnt/beta-catenin pathway without exerting trans-acting transcriptional ability.
Masui O; Ueda Y; Tsumura A; Koyanagi M; Hijikata M; Shimotohno K
Int J Mol Med; 2002 May; 9(5):489-93. PubMed ID: 11956654
[TBL] [Abstract][Full Text] [Related]
5. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
[TBL] [Abstract][Full Text] [Related]
6. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
7. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
Dihlmann S; Siermann A; von Knebel Doeberitz M
Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
[TBL] [Abstract][Full Text] [Related]
8. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells.
Cho HH; Song JS; Yu JM; Yu SS; Choi SJ; Kim DH; Jung JS
FEBS Lett; 2008 Mar; 582(5):616-22. PubMed ID: 18242184
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.
Williams JL; Nath N; Chen J; Hundley TR; Gao J; Kopelovich L; Kashfi K; Rigas B
Cancer Res; 2003 Nov; 63(22):7613-8. PubMed ID: 14633677
[TBL] [Abstract][Full Text] [Related]
11. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.
Bafico A; Liu G; Goldin L; Harris V; Aaronson SA
Cancer Cell; 2004 Nov; 6(5):497-506. PubMed ID: 15542433
[TBL] [Abstract][Full Text] [Related]
12. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
[TBL] [Abstract][Full Text] [Related]
13. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.
Park CH; Chang JY; Hahm ER; Park S; Kim HK; Yang CH
Biochem Biophys Res Commun; 2005 Mar; 328(1):227-34. PubMed ID: 15670774
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
15. Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cells.
Kapitanović S; Cacev T; Antica M; Kralj M; Cavrić G; Pavelić K; Spaventi R
Exp Mol Pathol; 2006 Feb; 80(1):91-6. PubMed ID: 15963497
[TBL] [Abstract][Full Text] [Related]
16. The Wnt connection to tumorigenesis.
Behrens J; Lustig B
Int J Dev Biol; 2004; 48(5-6):477-87. PubMed ID: 15349822
[TBL] [Abstract][Full Text] [Related]
17. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling through canonical and non-canonical pathways: recent progress.
Widelitz R
Growth Factors; 2005 Jun; 23(2):111-6. PubMed ID: 16019432
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas.
Fujita M; Furukawa Y; Tsunoda T; Tanaka T; Ogawa M; Nakamura Y
Cancer Res; 2001 Nov; 61(21):7722-6. PubMed ID: 11691783
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
